Harbor Advisory Corp’s Pfizer PFE Stock Holding History

Harbor Advisory Corp’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.12M	Sell	171,028 -7,630	-4%	-$200K	1.1%	29
2026 Q1	$5.02M	Sell	178,658 -3,699	-2%	-$98.5K	1.51%	27
2025 Q4	$4.54M	Sell	182,357 -7,567	-4%	-$191K	1.37%	25
2025 Q3	$4.84M	Sell	189,924 -38	-0%	-$938	1.43%	25
2025 Q2	$4.6M	Buy	189,962 +122,968	+184%	+$2.87M	1.47%	24
2025 Q1	$1.7M	Sell	66,994 -34,861	-34%	-$912K	0.57%	45
2024 Q4	$2.7M	Sell	101,855 -24,417	-19%	-$662K	0.89%	38
2024 Q3	$3.65M	Buy	126,272 +3,640	+3%	+$106K	1.19%	31
2024 Q2	$3.43M	Sell	122,632 -733	-0.6%	-$20.2K	1.19%	32
2024 Q1	$3.42M	Buy	123,365 +217	+0.2%	+$6.02K	1.17%	32
2023 Q4	$3.55M	Buy	123,148 +14,871	+14%	+$450K	1.27%	29
2023 Q3	$3.59M	Buy	108,277 +1,685	+2%	+$59.6K	1.3%	29
2023 Q2	$3.91M	Buy	106,592 +1,851	+2%	+$72K	1.38%	25
2023 Q1	$4.27M	Buy	104,741 +1,279	+1%	+$55.2K	1.63%	26
2022 Q4	$5.3M	Buy	103,462 +2,700	+3%	+$129K	2.17%	16
2022 Q3	$4.41M	Buy	100,762 +5,284	+6%	+$257K	2.03%	20
2022 Q2	$5.01M	Buy	95,478 +10,371	+12%	+$528K	2.19%	20
2022 Q1	$4.41M	Sell	85,107 -3,000	-3%	-$156K	1.77%	22
2021 Q4	$5.2M	Buy	88,107 +7,525	+9%	+$373K	2.11%	19
2021 Q3	$3.47M	Buy	80,582 +5,300	+7%	+$235K	1.5%	25
2021 Q2	$2.95M	Buy	+75,282	New	+$2.93M	1.33%	27

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Harbor Advisory Corp's PFE Position: Q2 2026 in Review

Harbor Advisory Corp reduced its Pfizer (PFE) stake by 4.3% in Q2 2026, selling an estimated $200K and leaving 171,028 shares worth $4.12M. The position accounts for 1.1% of the portfolio, ranked #29.

Harbor Advisory Corp first reported a position in PFE in Q2 2021 and has held it in 21 quarters since. The position peaked at $5.3M in Q4 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Harbor Advisory Corp held 171,028 shares of Pfizer worth $4.12M as of Q2 2026.
Harbor Advisory Corp sold 7,630 Pfizer shares in Q2 2026, an estimated $200K.
Pfizer made up 1.1% of Harbor Advisory Corp's portfolio in Q2 2026, its #29 holding.
Harbor Advisory Corp first reported a position in Pfizer in Q2 2021 and has held it in 21 quarters since.
Harbor Advisory Corp's Pfizer position peaked at $5.3M in Q4 2022.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Harbor Advisory Corp's 13F filing for Q2 2026, filed 13 Aug 2026.